- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.14 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 6 residues within 4Å:- Chain A: E.97, D.100, P.101, Q.102, K.107, W.108
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.100, A:P.101, A:W.108
- Water bridges: A:R.103
GOL.4: 4 residues within 4Å:- Chain A: N.53, I.59, Y.62, E.94
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.54
GOL.8: 6 residues within 4Å:- Chain B: E.97, D.100, P.101, Q.102, K.107, W.108
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.100, B:P.101, B:W.108
- Water bridges: B:R.103
GOL.9: 4 residues within 4Å:- Chain B: N.53, I.59, Y.62, E.94
No protein-ligand interaction detected (PLIP)GOL.13: 6 residues within 4Å:- Chain C: E.97, D.100, P.101, Q.102, K.107, W.108
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:D.100, C:P.101, C:W.108
- Water bridges: C:R.103
GOL.14: 4 residues within 4Å:- Chain C: N.53, I.59, Y.62, E.94
1 PLIP interactions:1 interactions with chain C- Water bridges: C:R.54
- 3 x HAR: N-OMEGA-HYDROXY-L-ARGININE(Non-covalent)
HAR.5: 14 residues within 4Å:- Chain A: H.152, H.177, D.179, N.181, S.188, H.192, G.193, D.234, D.283, D.285, T.297, E.328
- Ligands: MN.1, MN.2
19 PLIP interactions:19 interactions with chain A- Hydrogen bonds: A:N.181, A:S.188, A:H.192, A:D.234, A:T.297, A:T.297, A:T.297, A:E.328
- Water bridges: A:N.190, A:G.193, A:D.234, A:T.297, A:T.297
- Salt bridges: A:D.175, A:D.179, A:D.283, A:D.285, A:E.328
- pi-Cation interactions: A:H.192
HAR.10: 14 residues within 4Å:- Chain B: H.152, H.177, D.179, N.181, S.188, H.192, G.193, D.234, D.283, D.285, T.297, E.328
- Ligands: MN.6, MN.7
18 PLIP interactions:18 interactions with chain B- Hydrogen bonds: B:N.181, B:S.188, B:H.192, B:D.234, B:T.297, B:T.297, B:E.328
- Water bridges: B:N.190, B:G.193, B:D.234, B:T.297, B:T.297
- Salt bridges: B:D.175, B:D.179, B:D.283, B:D.285, B:E.328
- pi-Cation interactions: B:H.192
HAR.15: 14 residues within 4Å:- Chain C: H.152, H.177, D.179, N.181, S.188, H.192, G.193, D.234, D.283, D.285, T.297, E.328
- Ligands: MN.11, MN.12
18 PLIP interactions:18 interactions with chain C- Hydrogen bonds: C:N.181, C:S.188, C:H.192, C:D.234, C:T.297, C:T.297, C:T.297
- Water bridges: C:N.190, C:G.193, C:D.234, C:T.297, C:T.297
- Salt bridges: C:D.175, C:D.179, C:D.283, C:D.285, C:E.328
- pi-Cation interactions: C:H.192
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hai, Y. et al., Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis. Biochemistry (2014)
- Release Date
- 2014-07-16
- Peptides
- Arginase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
CC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.14 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 3 x HAR: N-OMEGA-HYDROXY-L-ARGININE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hai, Y. et al., Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis. Biochemistry (2014)
- Release Date
- 2014-07-16
- Peptides
- Arginase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
CC
C